.jpg "DENTSPLY SIRONA Inc (NASDAQ: XRAY)")
H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on DENTSPLY SIRONA Inc (NASDAQ: XRAY) today and set a price target of $40. The company’s shares closed yesterday at $39.66, close to its 52-week low of $37.70.
Selvaraju wrote:
“Our price target is derived from a comparable universe-based approach, which utilizes a price-to-earnings (P/E) multiple calculated from a group of peer companies in the medical and dental equipment arenas.”
According to TipRanks.com, Selvaraju is a 3-star analyst with an average return of 3.2% and a 46.9% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Biospecifics Technologies Corp, EyePoint Pharmaceuticals Inc, and Bausch Health Companies Inc.
DENTSPLY SIRONA Inc has an analyst consensus of Hold, with a price target consensus of $42.43.
See today’s analyst top recommended stocks >>
The company has a one-year high of $68.98 and a one-year low of $37.70. Currently, DENTSPLY SIRONA Inc has an average volume of 2.87M.
Based on the recent corporate insider activity of 112 insiders, corporate insider sentiment is negative on the stock. Most recently, in June 2018, Michael J. Coleman, a Director at XRAY sold 6,038 shares for a total of $265,503.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment and Consumables segments.
